| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.009 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |